Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- (Olfactory Dysfunction group) You have a clear problem with your sense of smell, such as distorted smells (parosmia), a low score on a standard smell test (TDI score of 24 or below), or you rate your own smell impairment as 5 out of 10 or higher on a simple scale
- (Control group) You have a normal sense of smell, confirmed by a standard smell test (TDI score above 30.5)
Who may not be able to join:
- You have a known condition affecting the lining inside your nose that could interfere with your sense of smell or affect the study results
- You are currently taking blood-thinning medication (anticoagulation therapy)
- You have an allergy to local anaesthetics (the numbing medicines used to reduce pain or sensation in a specific area)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laura van Gerven, UZ/KU Leuven
Phone: +3216336342
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Analysis of olfactory cleft biopsies; Analysis of olfactory cytobrushes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.